PAPER Wang Q, Yang S, Zhang X, Zhang S, Chen L, Wang W, Chen N, Yan J
SEARCH RESULTS
270360 RESULTS
PAPER Dong J, Tong W, Liu M, Liu M, Liu J, Jin X, Chen J, Jia H, Gao M, Wei M, Duan Y, Zhong X
Endosomal traffic disorders: a driving force behind neurodegenerative diseases.
Transl Neurodegener. 2024 Dec 24;13(1):66. PubMed.PAPER Wiseman JA, Fu Y, Faull RL, Turner CP, Curtis MA, Halliday GM, Dieriks BV
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's disease.
Transl Neurodegener. 2024 Dec 27;13(1):67. PubMed.PAPER Padovani A, Pilotto A, Pelucchi S, D'Andrea L, Stringhi R, Gorla F, Aksan B, Caratozzolo S, Benussi A, Galli A, Tirloni C, Mauceri D, Canale A, Archetti S, Borroni B, Di Luca M, Marcello E
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer's disease and correlates with tau pathology.
Transl Neurodegener. 2025 Jan 16;14(1):1. PubMed.PAPER Xu B, Lei X, Yang Y, Yu J, Chen J, Xu Z, Ye K, Zhang J
Peripheral proteinopathy in neurodegenerative diseases.
Transl Neurodegener. 2025 Jan 16;14(1):2. PubMed.PAPER Xue YY, Zhang ZS, Lin RR, Huang HF, Zhu KQ, Chen DF, Wu ZY, Tao QQ
Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.
Transl Neurodegener. 2025 Jan 17;14(1):3. PubMed. Corrected paper.PAPER Ou K, Jia Q, Li D, Li S, Li XJ, Yin P
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease.
Transl Neurodegener. 2025 Jan 21;14(1):4. PubMed.PAPER Wang Q, Yang S, Zhang X, Zhang S, Chen L, Wang W, Chen N, Yan J
Correction: Inflammasomes in neurodegenerative diseases.
Transl Neurodegener. 2025 Jan 23;14(1):5. PubMed. Corrected paper.PAPER Kim BH, Kim S, Nam Y, Park YH, Shin SM, Moon M
Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.
Transl Neurodegener. 2025 Jan 27;14(1):6. PubMed.PAPER Wiseman JA, Turner CP, Faull RL, Halliday GM, Dieriks BV
Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.
Transl Neurodegener. 2025 Feb 7;14(1):7. PubMed.PAPER Choquet D, Opazo P, Zhang H
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
Transl Neurodegener. 2025 Feb 11;14(1):8. PubMed.PAPER Liu N, Li R, Huang X, Lakso M, Wong G
The C. elegans gba-3 gene encodes a glucocerebrosidase that exacerbates α-synuclein-mediated impairments in deletion mutants.
Transl Neurodegener. 2025 Feb 13;14(1):9. PubMed.PAPER Chen L, Wang C, Qin L, Zhang H
Parkinson's disease and glucose metabolism impairment.
Transl Neurodegener. 2025 Feb 17;14(1):10. PubMed.PAPER Anaya, Lees, de Silva
Tau Gene Promoter rs242557 and Allele-Specific Protein Binding
Transl Neurosci 2011 2(2):76-205. .PAPER Schwartz E, Wicinski B, Schmeidler J, Haroutunian V, Hof PR
CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.
Transl Neurosci. 2010 Jan 1;1(4):292-299. PubMed.Current Filters
- TYPE: Paper x